HOSPITAL REPORT
While the rate of new drug shortages has fallen, manufacturing problems and import bans continue to cause shortages of certain medications. More |
|
FDA
Evolocumab is the second drug FDA has approved in a new class of drugs known as PCSK9 inhibitors.
More |
EDITOR'S CHOICE
Researchers at Boston Medical Center, with help from CVS Health and Rhode Island Hospital, plan to study pharmacy-based naloxone rescue kits. More |
Inside The Latest Issue
|
|
|